Carroll Financial Associates’s Virtus Biotech ETF BBP Stock Holding History

Carroll Financial Associates’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-253	Closed	-$11K	–	1451
2019 Q4	$11K	Hold	253	–	–	﹤0.01%	1015
2019 Q3	$9K	Hold	253	–	–	﹤0.01%	1027
2019 Q2	$10K	Hold	253	–	–	﹤0.01%	1007
2019 Q1	$11K	Hold	253	–	–	﹤0.01%	907
2018 Q4	$9K	Hold	253	–	–	﹤0.01%	876
2018 Q3	$11K	Hold	253	–	–	﹤0.01%	861
2018 Q2	$11K	Hold	253	–	–	﹤0.01%	830
2018 Q1	$10K	Hold	253	–	–	﹤0.01%	826
2017 Q4	$10K	Hold	253	–	–	﹤0.01%	819
2017 Q3	$10K	Hold	253	–	–	﹤0.01%	809
2017 Q2	$10K	Hold	253	–	–	﹤0.01%	827
2017 Q1	$9K	Hold	253	–	–	﹤0.01%	852
2016 Q4	$8K	Hold	253	–	–	﹤0.01%	838
2016 Q3	$8K	Hold	253	–	–	﹤0.01%	854
2016 Q2	$6K	Hold	253	–	–	﹤0.01%	886
2016 Q1	$6K	Hold	253	–	–	﹤0.01%	852
2015 Q4	$7K	Buy	253 +3	+1%	+$91	﹤0.01%	795
2015 Q3	$7K	Hold	250	–	–	﹤0.01%	776
2015 Q2	$9K	Buy	+250	New	+$8.21K	﹤0.01%	723

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SMG

Smart Money Group Eastland, Texas $390M AUM 21.29% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

FAIM

Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Carroll Financial Associates's BBP Position: Q1 2020 in Review

Carroll Financial Associates sold out of Virtus Biotech ETF (BBP) in Q1 2020, closing a stake of 253 shares — an estimated $11K sold.

Carroll Financial Associates first reported a position in BBP in Q2 2015 and held it in 19 quarters. The position peaked at $11K in Q4 2019. 12 funds tracked by Wall St. Rank hold BBP as of Q1 2020.

Carroll Financial Associates reported no remaining Virtus Biotech ETF position as of Q1 2020 after selling out during the quarter.
Carroll Financial Associates sold 253 Virtus Biotech ETF shares in Q1 2020, an estimated $11K.
Carroll Financial Associates first reported a position in Virtus Biotech ETF in Q2 2015 and held it in 19 quarters.
Carroll Financial Associates's Virtus Biotech ETF position peaked at $11K in Q4 2019.
12 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2020.

Based on Carroll Financial Associates's 13F filing for Q1 2020, filed 10 Apr 2020.